Unijules.com

Hormonals PDF Print E-mail

TONABOLIN 50
(Nandrolone Decanoate Injection BP 50 mg./ml.)

DENBOL 25
(Nandrolone Decanoate Injection BP 25 mg./ml.)

DENBOL 50
(Nandrolone Decanoate Injection BP 50 mg./ml.)

DENBOL 100
(Nandrolone Decanoate Injection BP 100 mg./ml.)

ANDROSTERON
(Testosterone Propionate injection BP 25 mg./ml.)

TONABOLIN 100
(Testosterone Propionate BP 20 mg.+ testosterone Phenyl Propionate BP 40 mg.

+ Testosterone Isocaproate BP 40 mg.+ Benzyl Alcohol BP 50 mg. + Arachis Oil BP q.s.)

TONABOLIN 250
(Testosterone Propionate BP 30 mg.+ testosterone Phenyl Propionate BP 60 mg.

+ Testosterone Isocaproate BP 60 mg.+ testosterone Decanoate BP 100 mg.

+ Benzyl Alcohol BP 50 mg.+ Arachis Oil BP q.s.)


MEDROXY PROGESTERONE ACETATE
(Medroxy Progesterone Acetate Injection BP 150 mg./ml.)

PROGERON 50
(Progesterone Injection BP 50 mg./ml.)

PROGERON 100
(Progesterone Injection BP 50 mg./ml.)

PROMENTON DEPOT.
(Hydroxyprogesterone Injection Injection BP 250 mg./ml.)

ONABOLIN
(Nandrolone Phenylpropionate Injection BP 25 mg./ml.)

DEPO-MEROL
(Methylprednisolone Acetate Injection BP)

 
< Prev   Next >

UNIQUE INNOVATIONS

Other Links...

 



You are here  :Home arrow Allopathic Range arrow Hormonals
Unijules Life Sciences Limited is proposing – subject to receipt of requisite approvals, market conditions and other considerations - a public issue of its equity shares. The Draft Red Herring Prospectus has been filed by the Company with SEBI and is available on SEBI website at www.sebi.gov.in as well as on the Book Running Lead Managers website www.rathi.com.

Investors should note that an investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the section titled ‘Risk Factors’ of the DRHP.